In the rodent model, Chen et al. demonstrated that ELABELA overexpression prevented DOCA/salt-induced hypertension by blocking NADPH oxidase/ROS/NLRP3 signaling pathway in the kidney, which suggests a potential role of ELABELA in treating salt-sensitive hypertension [60]. The gene discussed is APELA; the disease is hypertensive disorder.